The impact of IDH mutations on AML prognosis remains somewhat debatable, although generally, a minor outcome is seen with IDH1 mutations, and a relatively favorable prognosis may be seen with IDH2 mutations. Here, IDH1 is linked to acute myeloid leukemia.